LU90378I2 - Tetravac - Google Patents

Tetravac

Info

Publication number
LU90378I2
LU90378I2 LU90378C LU90378C LU90378I2 LU 90378 I2 LU90378 I2 LU 90378I2 LU 90378 C LU90378 C LU 90378C LU 90378 C LU90378 C LU 90378C LU 90378 I2 LU90378 I2 LU 90378I2
Authority
LU
Luxembourg
Prior art keywords
carbonate buffer
tetravac
detoxification
solubilization
bacteria
Prior art date
Application number
LU90378C
Other languages
English (en)
French (fr)
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of LU90378I2 publication Critical patent/LU90378I2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
LU90378C 1986-04-16 1999-03-29 Tetravac LU90378I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8605456A FR2597344B1 (fr) 1986-04-16 1986-04-16 Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.

Publications (1)

Publication Number Publication Date
LU90378I2 true LU90378I2 (fr) 1999-05-31

Family

ID=9334300

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90378C LU90378I2 (fr) 1986-04-16 1999-03-29 Tetravac

Country Status (12)

Country Link
US (1) US4774086A (xx)
EP (1) EP0242301B1 (xx)
JP (3) JP2563797B2 (xx)
AT (1) ATE81782T1 (xx)
AU (1) AU601415B2 (xx)
CA (1) CA1328070C (xx)
DE (3) DE3782356T2 (xx)
ES (1) ES2000435T3 (xx)
FR (1) FR2597344B1 (xx)
GR (2) GR880300043T1 (xx)
LU (1) LU90378I2 (xx)
ZA (1) ZA872712B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
US5032398A (en) * 1986-08-01 1991-07-16 Kaslow Harvey R Selective modification of the catalytic subunit of pertussis toxin
US5165927A (en) * 1986-08-01 1992-11-24 University Of Southern California Composition with modified pertussis toxin
US4845036A (en) * 1987-02-03 1989-07-04 The United States Of America As Represented By The Department Of Health And Human Services Process for isolation of the B oligomer of pertussis toxin
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
KR102426041B1 (ko) * 2017-08-01 2022-07-29 주식회사 녹십자 냉동 및 해동 과정을 포함하는 백일해균 유래 단백질 수득 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) * 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4500639A (en) * 1981-10-15 1985-02-19 Teijin Limited Culturing Bordetella in media containing etherified cyclodextrin
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6098988A (ja) * 1983-11-01 1985-06-01 Chemo Sero Therapeut Res Inst Ｌｐｆ−ｈａの精製法
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin
JPS60237027A (ja) * 1984-05-07 1985-11-25 Chemo Sero Therapeut Res Inst 線維状赤血球凝集素の精製方法
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine

Also Published As

Publication number Publication date
FR2597344A1 (fr) 1987-10-23
DE19875021I2 (de) 2010-07-01
DE3782356T2 (de) 1993-04-29
JP2563797B2 (ja) 1996-12-18
JPS62258326A (ja) 1987-11-10
JP2599259B2 (ja) 1997-04-09
ZA872712B (en) 1987-10-05
GR880300043T1 (en) 1988-10-18
DE3782356D1 (de) 1992-12-03
JPH08225463A (ja) 1996-09-03
CA1328070C (fr) 1994-03-29
ATE81782T1 (de) 1992-11-15
US4774086A (en) 1988-09-27
AU601415B2 (en) 1990-09-13
EP0242301B1 (fr) 1992-10-28
FR2597344B1 (fr) 1989-06-23
JP2599260B2 (ja) 1997-04-09
GR3006840T3 (xx) 1993-06-30
JPH08231421A (ja) 1996-09-10
ES2000435A4 (es) 1988-03-01
AU7158187A (en) 1987-10-22
EP0242301A1 (fr) 1987-10-21
ES2000435T3 (es) 1994-02-01
DE242301T1 (de) 1988-06-09

Similar Documents

Publication Publication Date Title
DK512686D0 (da) Thrombinpraeparater, deres fremstilling og anvendelse
DE69529219T2 (de) Helicobacter proteine und impstoffe
ATE61937T1 (de) Antigenische zubereitungen und isolierung von solchen zubereitungen.
DE68924162D1 (de) Stressproteine und verwendungen dafür.
AP8700068A0 (en) Vaccine and method of preparation.
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
ATE279940T1 (de) Behandlung und prävention von helicobacter- infektionen
LU91595I2 (fr) Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib)
SE8404707L (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
LU90378I2 (fr) Tetravac
DE3784728T2 (de) Reinigung von rekombinantem interleukin-1.
DE69527986T2 (de) Antigene arznei zur behandlung oder vorbeugung
ES8606485A1 (es) Procedimiento para preparar una solucion antigenica libre decelulas
DE3785157T2 (de) Verfahren zur herstellung von toxoid.
ES2088431T3 (es) Preparacion biologica y su utilizacion.
ES557404A0 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
ATE107516T1 (de) Pasteurella-impfstoff.
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
ATE420951T1 (de) Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
DK0623170T3 (da) Vacciner baseret på streptokinase
PT96022A (pt) Processo para a prparacao de toxina bordetella pertussis geneticamente modificada e de nova vacina contra a tosse convulsa contendo a referida toxina
ATE87658T1 (de) Verfahren zur selektiven biokonversion von isosorbid-dinitrat.
FR2601250B1 (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.